Impaired water reabsorption in mice deficient in the type VI adenylyl cyclase (AC6)

FEBS Letters

Volumn 584, Issue 13, 2010, Pages 2883-2890

  Chien, Chen Li ^a,b   Wu, Yu Shuo ^a,b   Lai, Hsing Lin ^b   Chen, Yen Hui ^b   Jiang, Si Tse ^c   Shih, Chia Ming ^b   Lin, Sui Shan ^b   Chang, Chen ^b   Chern, Yijuang ^a,b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c NATIONAL APPLIED RESEARCH LABORATORIES   (Taiwan)

Author keywords

Adenylyl cyclase; CAMP; Collecting duct; Kidney; Renal tubule; Water reabsorption

Indexed keywords

ADENYLATE CYCLASE; ADENYLYL CYCLASE 6; FORSKOLIN; UNCLASSIFIED DRUG; VASOPRESSIN V2 RECEPTOR;

ADULT ANIMAL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENOTYPE; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY COLLECTING TUBULE; MOUSE; NEPHRON; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; URINALYSIS; WATER ABSORPTION; WILD TYPE;

ADENYLATE CYCLASE; ANIMALS; CYCLIC AMP; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULES, COLLECTING; MAGNETIC RESONANCE IMAGING; MICE; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WATER;

MUS;

EID: 77953718853     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.05.004     Document Type: Article

References (22)

1. Pierre S., Eschenhagen T., Geisslinger G., Scholich K. Capturing adenylyl cyclases as potential drug targets. Nat. Rev. Drug Discovery 2009, 8:321-335.
2. Pavan B., Biondi C., Dalpiaz A. Adenylyl cyclases as innovative therapeutic goals. Drug Discovery Today 2009, 14:982-991.
3. 2+ increase in the inhibition of intracellular cAMP content. Cell. Signal. 1999, 11:651-663.
4. 2+-inhibitable adenylyl cyclases along the renal tubule. Functional consequences for regulation of the camp content. J. Biol. Chem. 1996, 271:19264-19271.
5. Wang T., Brown M.J. Differential expression of adenylyl cyclase subtypes in human cardiovascular system. Mol. Cell. Endocrinol. 2004, 223:55-62.
6. Beazely M.A., Watts V.J. Regulatory properties of adenylate cyclases type 5 and 6: a progress report. Eur. J. Pharmacol. 2006, 535:1-12.
7. Krishnan R., Eley L., Sayer J.A. Urinary concentration defects and mechanisms underlying nephronophthisis. Kidney Blood Press. Res. 2008, 31:152-162.
8. Lai N.C., Tang T., Gao M.H., Saito M., Takahashi T., Roth D.M., Hammond H.K. Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice. J. Am. Coll. Cardiol. 2008, 51:1490-1497.
9. Liu F.C., Wu G.C., Hsieh S.T., Lai H.L., Wang H.F., Wang T.W., Chern Y. Expression of type VI adenylyl cyclase in the central nervous system: implication for a potential regulator of multiple signals in different neurotransmitter systems. FEBS Lett. 1998, 436:92-98.
10. Fenton R.A., Knepper M.A. Muse models and the urinary concentrating mechanism in the new millennium. Physiol. Rev. 2007, 87:1083-1112.
11. + transport by soluble adenylyl cyclase in kidney collecting duct cells. J. Biol. Chem. 2009, 284:5774-5783.
12. Birnbaumer M. Vasopressin receptors. Trends Endocrinol. Metab. 2000, 11:406-410.
13. Nielsen S., Chou C.L., Marples D., Christensen E.I., Kishore B.K., Knepper M.A. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc. Natl. Acad. Sci. USA 1995, 92:1013-1017.
14. Lee E.C., Yu D., Martinez de Velasco J., Tessarollo L., Swing D.A., Court D.L., Jenkins N.A., Copeland N.G. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 2001, 73:56-65.
15. Chern Y., Lai H.L., Fong J.C., Liang Y. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Mol. Pharmacol. 1993, 44:950-958.
16. 2A adenosine receptor gene: a 4.8kb promoter-proximal DNA fragment confers selective expression in the central nervous system. Eur. J. NeuroSci. 2003, 18:1786-1796.
17. Helies-Toussaint C., Aarab L., Gasc J.M., Verbavatz J.M., Chabardes D. Cellular localization of type 5 and type 6 ACs in collecting duct and regulation of cAMP synthesis. Am. J. Physiol. Renal Physiol. 2000, 279:F185-F194.
18. Masyuk A.I., et al. Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G725-G734.
19. Chen L., et al. Regulation of renin in mice with Cre recombinase-mediated deletion of G protein Gs in juxtaglomerular cells. Am. J. Physiol. Renal Physiol. 2007, 292:F27-37.
20. Nishimoto G., Zelenina M., Li D., Yasui M., Aperia A., Nielsen S., Nairn A.C. Arginine vasopressin stimulates phosphorylation of aquaporin-2 in rat renal tissue. Am. J. Physiol. Renal Physiol. 1999, 276:F254-F259.
21. 269 potentiates plasma membrane retention of aquaporin-2. J. Biol. Chem. 2008, 283:24617-24627.
22. Buckley D.L., Shurrab A.E., Cheung C.M., Jones A.P., Mamtora H., Kalra P.A. Measurement of single kidney function using dynamic contrast-enhanced MRI: comparison of two models in human subjects. J. Magn. Reson. Imaging 2006, 24:1117-1123.